MICHELE KESSLER: Open Payments
NPI 1215161781 · ROXBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,781 in 77 payments from 14 companies in 2025. Trend: 2023 $1,309 · 2024 $1,414 · 2025 $1,781
Food & beverage: $1,781
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 23 | $428 |
| MAYNE PHARMA COMMERCIAL LLC | 8 | $334 |
| Biogen, Inc. | 6 | $220 |
| Sumitomo Pharma America, Inc. | 9 | $171 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $139 |
| Novo Nordisk Inc | 4 | $136 |
| Astellas Pharma US Inc | 6 | $108 |
| Evofem Biosciences, Inc. | 5 | $72 |
| Exeltis, USA Inc. | 3 | $55 |
| PFIZER INC. | 2 | $38 |
Products named: ZURZUVAE, ZEPBOUND, MYFEMBREE, MOUNJARO, Wegovy, Kyleena, BIJUVA, Veozah.
Industry payments across NC — which companies pay providers there.
